cbdMD, Inc.
For the period ended Mar 30, 2026. Filed Feb 12, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Mar 30, 2026 · Filed Feb 12, 2026
Use the contents to explore the available documents and sections.
Contents
After Each Reverse Split Ratio
| Current | 1:2 | 1:10 | |
|---|---|---|---|
| Common Stock Authorized(1) | 150,000,000 | 150,000,000 | 150,000,000 |
| Number of Shares of Common Stock Reserved for Issuance(2) | 2,131,858 | 1,065,929 | 213,186 |
| Number of Shares of Common Stock Authorized but Unissued and Unreserved | 147,868,142 | 148,934,071 | 149,786,814 |
| Price per share, based on the closing price of our Common Stock on the Record Date | $0.8692 | $1.7384 | $8.692 |
| (1) | The Reverse Split will not have any impact in the number of shares of common stock we are authorized to issue under our articles of incorporation, as amended. |
| (2) | Consists of: |
| ● | 591,207 shares of common stock issuable upon the conversion of outstanding shares of Series B Convertible Preferred Stock convertible at $1.00 per share on the Record Date*; |
| ● | 1,000,000 shares of common stock issuable upon the conversion of outstanding shares of Series C Convertible Preferred Stock convertible at $2.25 per share on the Record Date*; |
| ● | 5,517 shares of common stock issuable upon the exercise of outstanding and unexercised options; |
| ● | 4,233 shares of common stock issuable upon vesting of unvested RSU awards; |
| ● | 5,901 shares of common stock issuable upon the exercise of outstanding warrants; and |
| ● | 525,000 shares of common stock issuable under an earnout. |
- Conversion price subject to adjustment following the Record Date.
After the effective date of the Reverse Split, our common stock would have a new CUSIP number, a number used to identify our common stock.
Our common stock is currently registered under Section 12(b) of the Exchange Act, and we are subject to the periodic reporting and other requirements of the Exchange Act. The proposed Reverse Split will not affect the registration of our common stock under the Exchange Act. Our common stock would continue to be reported on NYSE under the symbol “YCBD.”
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.